Literature DB >> 23576481

Screening for breast cancer-related lymphedema: the need for standardization.

Jean O'Toole1, Lauren S Jammallo, Cynthia L Miller, Melissa N Skolny, Michelle C Specht, Alphonse G Taghian.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23576481      PMCID: PMC3639519          DOI: 10.1634/theoncologist.2012-0387

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


× No keyword cloud information.
  16 in total

1.  Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection.

Authors:  Takamaru Ashikaga; David N Krag; Stephanie R Land; Thomas B Julian; Stewart J Anderson; Ann M Brown; Joan M Skelly; Seth P Harlow; Donald L Weaver; Eleftherios P Mamounas; Joseph P Costantino; Norman Wolmark
Journal:  J Surg Oncol       Date:  2010-08-01       Impact factor: 3.454

2.  The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors.

Authors:  Rebecca J Tsai; Leslie K Dennis; Charles F Lynch; Linda G Snetselaar; Gideon K D Zamba; Carol Scott-Conner
Journal:  Ann Surg Oncol       Date:  2009-04-14       Impact factor: 5.344

3.  Infrared optoelectronic volumetry, the ideal way to measure limb volume.

Authors:  S Tierney; M Aslam; K Rennie; P Grace
Journal:  Eur J Vasc Endovasc Surg       Date:  1996-11       Impact factor: 7.069

4.  Minimal limb volume change has a significant impact on breast cancer survivors.

Authors:  J N Cormier; Y Xing; I Zaniletti; R L Askew; B R Stewart; J M Armer
Journal:  Lymphology       Date:  2009-12       Impact factor: 1.286

5.  Comparison of relative versus absolute arm size change as criteria for quantifying breast cancer-related lymphedema: the flaws in current studies and need for universal methodology.

Authors:  Marek Ancukiewicz; Cynthia L Miller; Melissa N Skolny; Jean O'Toole; Laura E Warren; Lauren S Jammallo; Michelle C Specht; Alphonse G Taghian
Journal:  Breast Cancer Res Treat       Date:  2012-06-19       Impact factor: 4.872

6.  Impact of lymphedema and arm symptoms on quality of life in breast cancer survivors.

Authors:  J M Hormes; C Bryan; L A Lytle; C R Gross; R L Ahmed; A B Troxel; K H Schmitz
Journal:  Lymphology       Date:  2010-03       Impact factor: 1.286

7.  Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study.

Authors:  Ya-Chen Tina Shih; Ying Xu; Janice N Cormier; Sharon Giordano; Sheila H Ridner; Thomas A Buchholz; George H Perkins; Linda S Elting
Journal:  J Clin Oncol       Date:  2009-03-16       Impact factor: 44.544

8.  Lymphedema secondary to breast cancer: how choice of measure influences diagnosis, prevalence, and identifiable risk factors.

Authors:  S Hayes; M Janda; B Cornish; D Battistutta; B Newman
Journal:  Lymphology       Date:  2008-03       Impact factor: 1.286

9.  Preoperative assessment enables the early diagnosis and successful treatment of lymphedema.

Authors:  Nicole L Stout Gergich; Lucinda A Pfalzer; Charles McGarvey; Barbara Springer; Lynn H Gerber; Peter Soballe
Journal:  Cancer       Date:  2008-06-15       Impact factor: 6.860

10.  Arm lymphoedema in a cohort of breast cancer survivors 10 years after diagnosis.

Authors:  Karin Johansson; Elin Branje
Journal:  Acta Oncol       Date:  2010       Impact factor: 4.089

View more
  11 in total

Review 1.  Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments.

Authors:  Tessa C Gillespie; Hoda E Sayegh; Cheryl L Brunelle; Kayla M Daniell; Alphonse G Taghian
Journal:  Gland Surg       Date:  2018-08

Review 2.  Use of technology to facilitate a prospective surveillance program for breast cancer-related lymphedema at the Massachusetts General Hospital.

Authors:  Lauren M Havens; Cheryl L Brunelle; Tessa C Gillespie; Madison Bernstein; Loryn K Bucci; Yara W Kassamani; Alphonse G Taghian
Journal:  Mhealth       Date:  2021-01-20

3.  Subclinical Lymphedema After Treatment for Breast Cancer: Risk of Progression and Considerations for Early Intervention.

Authors:  Loryn K Bucci; Cheryl L Brunelle; Madison C Bernstein; Amy M Shui; Tessa C Gillespie; Sacha A Roberts; George E Naoum; Alphonse G Taghian
Journal:  Ann Surg Oncol       Date:  2021-06-11       Impact factor: 5.344

4.  Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression?

Authors:  Michelle C Specht; Cynthia L Miller; Tara A Russell; Nora Horick; Melissa N Skolny; Jean A O'Toole; Lauren S Jammallo; Andrzej Niemierko; Betro T Sadek; Mina N Shenouda; Dianne M Finkelstein; Barbara L Smith; Alphonse G Taghian
Journal:  Breast Cancer Res Treat       Date:  2013-08-04       Impact factor: 4.872

Review 5.  Diagnostic Criteria for Breast Cancer-Related Lymphedema of the Upper Extremity: The Need for Universal Agreement.

Authors:  Yara W Kassamani; Cheryl L Brunelle; Tessa C Gillespie; Madison C Bernstein; Loryn K Bucci; Tracy Nassif; Alphonse G Taghian
Journal:  Ann Surg Oncol       Date:  2021-09-09       Impact factor: 5.344

6.  Establishing and sustaining a prospective screening program for breast cancer-related lymphedema at the massachusetts general hospital: lessons learned.

Authors:  Cheryl Brunelle; Melissa Skolny; Chantal Ferguson; Meyha Swaroop; Jean O'Toole; Alphonse G Taghian
Journal:  J Pers Med       Date:  2015-05-20

7.  The prevalence of lymphoedema in women who attended an information and exercise class to reduce the risk of breast cancer-related upper limb lymphoedema.

Authors:  E Jeffs; A Purushotham
Journal:  Springerplus       Date:  2016-01-07

8.  Multi-center rater-blinded study of early intervention with the Hand Incubator for breast cancer-related lymphedema (the BEAT-EDEMA trial): Proposal of a research protocol.

Authors:  Hisao Ishii; Katsuyuki Iwatsuki; Masahiro Tatebe; Hitoshi Hirata; Toyone Kikumori; Nobuyuki Tsunoda; Ikuo Hyodo; Tomoko Ogawa; Naoki Unno
Journal:  Nagoya J Med Sci       Date:  2017-02       Impact factor: 1.131

Review 9.  Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers.

Authors:  Sandra Russo; Joan L Walker; Jay W Carlson; Jeanne Carter; Leigh C Ward; Allan Covens; Edward J Tanner; Jane M Armer; Sheila Ridner; Sandi Hayes; Alphonse G Taghian; Cheryl Brunelle; Micael Lopez-Acevedo; Brittany A Davidson; Mark V Schaverien; Sharad A Ghamande; Michael Bernas; Andrea L Cheville; Kathleen J Yost; Kathryn Schmitz; Barbara Coyle; Jeannette Zucker; Danielle Enserro; Stephanie Pugh; Electra D Paskett; Leslie Ford; Worta McCaskill-Stevens
Journal:  Gynecol Oncol       Date:  2020-11-04       Impact factor: 5.482

10.  Comparison of a novel algorithm quantitatively estimating epifascial fibrosis in three-dimensional computed tomography images to other clinical lymphedema grading methods.

Authors:  Kyo-In Koo; Myoung-Hwan Ko; Yongkwan Lee; Hye Won Son; Suwon Lee; Chang Ho Hwang
Journal:  PLoS One       Date:  2019-12-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.